ATNM
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM)
$25
About Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM)
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, discovery, and clinical development of targeted radiotherapies. It also develops and markets medicines for relapsed and refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Details
Daily high
$1.32
Daily low
$1.25
Price at open
--
52 Week High
$1.74
52 Week Low
$0.74
Market cap
40.2M
Dividend yield
-
Volume
1,201
Avg. volume
169,510
P/E ratio
3.59
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock News
Details
Daily high
$1.32
Daily low
$1.25
Price at open
--
52 Week High
$1.74
52 Week Low
$0.74
Market cap
40.2M
Dividend yield
-
Volume
1,201
Avg. volume
169,510
P/E ratio
3.59